Dividend stocks alert! Last chance to qualify- Kalyan Jewellers, Aarti Industries, Blue Jet, Bajaj Healthcare, others
NiveshIQ
Blue Jet Healthcare Ltd.
NiveshIQ has detected 5 active signals on BLUEJET. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeAbout Blue Jet Healthcare Ltd.
Blue Jet Healthcare Limited is a leading manufacturer and supplier of pharmaceutical intermediates and active pharmaceutical ingredients, with a diverse product portfolio that includes contrast media intermediates, niche pharmaceutical intermediates and APIs, and CDMO/CMO services. The company has a strong global presence, with operations in India, Norway, France, the United States, Italy, Sweden, and internationally. Recently, Blue Jet Healthcare reported a 25% surge in revenue, driven by growth in its pharmaceutical intermediates and APIs business. However, the company also reported a 17% decline in revenue in the first quarter of FY27, primarily due to a decline in its pharmaceutical intermediates segment. Despite this, the company's net income stood at ₹235 Cr, with a revenue of ₹886 C
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹710.32 Cr -1.40% | ₹1,026 Cr +44.50% | ₹947.32 Cr -7.70% |
| EBITDA Margin | 34.96% | 42.98% | 38.29% |
| Net Profit | ₹163.75 Cr +2.30% | ₹305.20 Cr +86.40% | ₹247.82 Cr -18.80% |
| EPS | ₹9.44 | ₹9.07 | ₹14.29 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Dividend stocks alert! Last chance to qualify- Kalyan Jewellers, Aarti Industries, Blue Jet, Bajaj Healthcare, others
Dividend stocks alert! Last chance to qualify- Kalyan Jewellers, Aarti Industries, Blue Jet, Bajaj Healthcare, others
Strategic Outlook
- Q1FY27 results: revenue ₹293 Cr, PAT ₹78 Cr, EPS ₹4.51, EBITDA margin 38.7%. Growth context: revenue QoQ +24.9%, PAT QoQ +21.6%. Street verdict: beat, revenue surprise -2.7%, PAT surprise +7.4%.
Product pipeline delivery, domestic demand, export mix, approvals, and margin discipline remain the key forward drivers ...
FY26 (last completed FY): revenue ₹947 Cr, PAT ₹248 Cr, EBITDA margin 38.3%, EPS ₹14.29. Year-on-year: revenue YoY -7.7%...
Everything you unlock with a free account
Frequently Asked Questions
What AI signals does NiveshIQ provide for Blue Jet Healthcare Ltd.?
NiveshIQ detects active intelligence signals for Blue Jet Healthcare Ltd. (BLUEJET) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Blue Jet Healthcare Ltd.?
Blue Jet Healthcare Ltd. operates in the Healthcare sector with a market capitalisation of ₹851,715.2L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.